Camurus
261 SEK -0,15 %1 investor følger denne virksomhed
Camurus is active in biotechnology. The company runs as a research-based pharmaceutical company and develops and distributes products for the treatment of severe and chronic diseases. Diseases treated with the company's products include, for example, cancer, endocrine disorders, and patients with opioid dependence. Camurus runs development projects under its own auspices and in partnership with international pharmaceutical companies. The company is headquartered in Lund.
Omsætning
956,34 mio.
EBIT %
7,52 %
P/E
258,42
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
CAMX
Daglig lav / høj pris
260 / 265,2
SEK
Markedsværdi
14,47 mia. SEK
Aktieomsætning
32 mio. SEK
Volumen
122 t
Seneste videoer
Finanskalender
Delårsrapport
18.07.2023
Delårsrapport
09.11.2023
Viser Alle indholdstyper
